These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14104357)

  • 1. DIRECT DETERMINATION OF FIBRINOLYTIC ACTIVITY OF HUMAN SALIVA.
    TAYLOR RG; DOKU HC; ROMERO J
    J Dent Res; 1964; 43():86-91. PubMed ID: 14104357
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The fibrinolytic activity in human saliva (author's transl)].
    Sasaki Y; Horiuchi K; Kitano S
    Josai Shika Daigaku Kiyo; 1978; 7(1):163-6. PubMed ID: 228779
    [No Abstract]   [Full Text] [Related]  

  • 4. [The normal fibrinolytic activity of the oral mucosa and saliva and in pathology].
    Zhad'ko SI
    Lik Sprava; 1994; (7-8):128-30. PubMed ID: 7900335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors of the fibrinolytic system in liver diseases].
    van de Loo J; Schmiesing G
    Thromb Diath Haemorrh; 1965 Nov; 14(3-4):580-91. PubMed ID: 4222263
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of bioresolving microspheric preparations of immobilized fibrinolysin on the fibrinolysis system].
    Bessolitsyna LA; Mazaev AB; Markosian RA; Suvorov AV; Torchilin VP
    Biull Eksp Biol Med; 1980; 89(1):16-8. PubMed ID: 6445763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 8. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic activity; inhibition of plasminogen activation.
    GORMSEN J
    Acta Med Scand; 1962 Dec; 172():657-63. PubMed ID: 13949315
    [No Abstract]   [Full Text] [Related]  

  • 10. FIBRINOLYTIC ACTIVITY OF THE NORMAL AND FIBROMYOMATOUS HUMAN UTERUS.
    RASMUSSEN J; ROBERTS HR; ASTRUP T
    Surg Gynecol Obstet; 1964 Jun; 118():1277-80. PubMed ID: 14177842
    [No Abstract]   [Full Text] [Related]  

  • 11. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifibrinolytic activity of human saliva components.
    Haze H; Eldor A; Garfunkel AA
    Thromb Res; 1980 Mar; 17(5):737-42. PubMed ID: 6446172
    [No Abstract]   [Full Text] [Related]  

  • 13. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 14. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.
    BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A
    Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046
    [No Abstract]   [Full Text] [Related]  

  • 15. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 18. ENZYMATIC AND PHYSIOLOGICAL STUDIES ON THE PROTEASES HETEROGENOUS TO THE BODY. I. SUBSTRATE SPECIFICITY, INHIBITORS, AND THE PHYSIOLOGICAL FATE OF ASPERKINASE.
    OSHIBA S; MIHARA H; HATA S; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():139-49. PubMed ID: 14160534
    [No Abstract]   [Full Text] [Related]  

  • 19. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrinolytic activity of saliva and blood--comparative study].
    Schulte W; Sorg B
    Dtsch Zahnarztl Z; 1967 Sep; 22(9):1101-6. PubMed ID: 4228623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.